SARTORIUS STEDIM BIOTECH (SDMHF:OTCMKTS)
$193 1 (0.5208%)
Analysed SARTORIUS STEDIM BIOTECH (SDMHF:OTCMKTS) News Sources
Sartorius to invest $3m for minority share in biotech start-up Nanotein
12-08-2025
pharmaceutical-technology.com
European Hidden Value Stocks That Might Be Priced Below Intrinsic Estimates
02-09-2025
yahoo.com
Discover 3 European Stocks Believed To Be Trading Below Intrinsic Value
02-10-2025
yahoo.com
Sartorius Stedim Biotech SA (SDMHF) Q4 2025 Earnings Call Highlights: Strong Profit Growth and ...
03-02-2026
yahoo.com
[Latest] Global Cell Therapy Raw Materials Market Size/Share Worth USD 29.3 Billion by 2035 at a 18.9% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)
11-02-2026
yahoo.com
European Stocks Possibly Trading Below Estimated Value May 2026
06-05-2026
yahoo.com
Sartorius Stedim Biotech SA (SDMHF) Q2 2026 Earnings Call Highlights: Strong Growth Amid Tariff ...
23-07-2026
yahoo.com
What is the current price of SARTORIUS STEDIM BIOTECH (SDMHF:OTCMKTS)?
The current price of SARTORIUS STEDIM BIOTECH (SDMHF:OTCMKTS) is $193.
SARTORIUS STEDIM BIOTECH (SDMHF:OTCMKTS) absolute price change since previous trading day?
The absolute price change of SARTORIUS STEDIM BIOTECH (SDMHF:OTCMKTS) since the previous trading day is $1.
SARTORIUS STEDIM BIOTECH (SDMHF:OTCMKTS) percentage price change since previous trading day?
The percentage price change of SARTORIUS STEDIM BIOTECH (SDMHF:OTCMKTS) since the previous trading day is 0.5208%.
What is the most recent average sentiment score for SARTORIUS STEDIM BIOTECH (SDMHF:OTCMKTS)?
The most recent average sentiment score for SARTORIUS STEDIM BIOTECH (SDMHF:OTCMKTS) is 75 out of 100.
What is the most recent average sentiment for SARTORIUS STEDIM BIOTECH (SDMHF:OTCMKTS)?
The most recent sentiment for SARTORIUS STEDIM BIOTECH (SDMHF:OTCMKTS) is .
SEC-8K** Filing Available For SARTORIUS STEDIM BIOTECH (SDMHF:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.